Kim et al. usedCRISPR/Cas9-mediated gene editing to target mutations in KRAS oncogene (KRAS G12C, G12D, and G12 V) in pancreaticcancer cells in mice and found that it inhibited cancer cell proliferationwithout affecting wild-type (WT) cells. The gene discussed is KRAS; the disease is cancer.